Цель исследования изучить влияние валсартана в виде монотерапии и его комбинации
с гидрохлоротиазидом (ГХТ) на скорость пульсовой волны (СПВ) и центральное …

Hypertension is the main risk factor for left ventricular hypertrophy and development of
diastolic heart failure. There is no yet treatment, which can effectively reduce mortality in …

Angiotensin II (ANGII) plays an important role in the pathogenesis of atherosclerosis by
inducing proliferation of vascular smooth muscle cells (VSMCs). In our study, we observed …

An external file that holds a picture, illustration, etc. Object name is bi-6-119-g005. jpg
Introduction: Nephrotoxicity as a side effect caused by the immunosuppressive drug …

This study describes the development and validation of a highly sensitive high-performance
liquid chromatographic method with fluorescence detection and on-line emission …

Valsartan is an oral angiotensin II subtype 1 receptor antagonist with well established
antihypertensive efficacy in adults. It is now approved in the EU and the US for the treatment …

Early initiation of rational and effective combination therapy consisting of antihypertensive
drugs with two different and complementary mechanisms of actions is increasingly …

Introduction: Angiotensin receptor blockers (ARBs) as a class are generally considered safe
and better tolerated than other antihypertensive drugs. The purpose of this report is to review …

Background Nephrotoxicity side effect of the immunosuppressive drug, cyclosporine A
(CsA), can be a major issue in transplantation medicine. Cyclosporine A–induced …

Introduction Structural and functional properties of the left ventricle (LV) wall have been
reported to be altered in hypertension, even at early stages of the disease. Abnormal …